ANGLE plc (ANPCF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 10:55AM EDT
| Previous Close | 0.1964 |
| Open | 0.1964 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.1964 - 0.1964 |
| 52 Week Range | 0.1320 - 0.5200 |
| Volume | |
| Avg. Volume | 9 |
| Market Cap | 51.178M |
| Beta (5Y Monthly) | 0.12 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1100 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
News DirectANGLE partners with AstraZeneca in groundbreaking oncology contract
ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with news the company has entered a significant contract with AstraZeneca, marking its second major collaboration with a l...
ACCESSWIREAngle PLC Announces New Commercial Agreement with AstraZeneca
ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D GUILDFORD, SURREY / ACCESSWIRE / April 24, 2024 / ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative ...
News DirectANGLE achieves breakthrough with EU patent for CellKeep technology, with the US to follow
ANGLE PLC chief executive Andrew Newland discussed significant advancements in the company's technology, including a European patent for the CellKeep slide, with US intellectual property protection...
© 2024 Yahoo. All rights reserved.